tradeMONSTER

Options Trading News

November 27, 2012  Tue 7:23 AM CT

ACAD: SEE CHART GET CHAIN FIND STRATEGIES

Primary and Secondary Endpoints Are Met

Acadia Phaemaceuticals announced successful top-line results for the Phase III trial of its Pimavanserin drug for patients with Parkinson’s disease psychosis. The compound met the primary endpoint by demonstrating highly significant antipsychotic efficacy using a nine-item scale. It also met a secondary endpoint for motoric tolerability. ACAD is up 160 percent before the bell on my tradeMONSTER platform!

Ralcorp Accepts ConAgra Takeover Offer

Ralcorp agreed to be purchased by ConAgra for $90 a share in cash. That's a nice premium for RAH, which closed at $70.23 yesterday, and the stock is up almost 27 percent in early trading.

Las Vegas Sands Rallies on Special Dividend

Las Vegas Sands announced that its board approved a special dividend of $2.75 a share in cash. LVS climbs more than 4 percent in the premarket.

Share this article with your friends


tradeMONSTER

Premium Services

Archived Webinar

The Art of Trading: Forgiving the Spread

Education & Strategy

The first derivative

The first of the Greeks to explore is delta, which is aptly described as the first derivative.Delta measures a stock's...

View more education articles »
optionMONSTER stockMONSTER tradeMONSTER